NgospelMedia.Net
NgospelMedia.net is The No. 1 International Urban Gospel Media Website, The Largest Repository of Your Favorite Gospel Entertainment Website, Worldwide, Nigeria. We Published Latest Nigerian and Foreign Gospel Music Downloads, Videos; Lyrics, Artiste Biography, Daily Devotionals. NgospelMedia is mainly a Christian Website, as the Domain Name Speaks; Gospel; Which is also tagged as a Gospel On-line Ministry for Souls Winning... 

Novavax shot 96% effective against COVID-19 in trial

0 154







- Advertisement -


The COVID-19 vaccine from Novavax was found to be 96 percent effective against the original strain of the coronavirus in new a UK trial, the company announced Thursday.

The shot from the Maryland-based company was also 86 percent effective against the more contagious variant first discovered in the UK and now spreading across the US and in New York City.

In a smaller South Africa trial, the Novavax vaccine was only around 55 percent effective in preventing disease when tested against volunteers primarily exposed to the new variant first identified there.

But in both the UK and South Africa trials, the shot was 100 percent effective in preventing serious illness and death.

The company will use the findings to seek authorization for the vaccine’s use in various countries. It was not immediately clear if it will seek FDA authorization based on the UK findings, or if it will wait for the completion of an ongoing US test.

Novavax COVID-19 vaccine
A new trial found the Novavax COVI-19 vaccine to be 96 percent effective against the original strain.
SOPA Images/LightRocket via Gett

The latest findings are in line with interim results announced in January, when the Novavax jab was also found to be 96 percent effective against the original coronavirus and around 86 percent effective against the UK variant.

Currently, there are three vaccines authorized for use in the U.S., from Pfizer-BioNTech, Moderna and Johnson & Johnson.

With Post wires

A volunteer getting the Novavax COVID-19 vaccine in a trial at St. George's University hospital in London on October 7, 2020.
A volunteer gets the Novavax COVID-19 vaccine in a trial at St. George’s University Hospital in London on Oct. 7, 2020.
Alastair Grant/AP

- Advertisement -

Subscribe to our newsletter
Sign up here to get the latest news, updates and special offers delivered directly to your inbox.
You can unsubscribe at any time

- Advertisement -

- related posts -

0 0 vote
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

NgospelMedia.Net and its partners uses cookies and similar technology to collect and analyze data information about the users of this website. We use this information to enhance the content, advertising and other services available on the site. Accept Read More

0
Would love your thoughts, please comment.x
()
x




Send this to a friend